BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
5-Amino + NAD+ (Oral), toote foto
Fat Loss

5-Amino + NAD+ (Oral)

Fat Loss

  • Saadetakse Saksamaalt

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

5-Amino + NAD+ (Oral) jaoks pole veel laborianalüüsi. Hääleta selle pooltLase ise testida, meie maksame pooleKõik laborianalüüsid

Teadmised

Kõik teemal 5-Amino + NAD+ (Oral)

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

Are there studies on this blend?

No. ClinicalTrials.gov lists no trial with 5-Amino-1MQ and PubMed none on the combination with an NAD+ building block (as of 25 October 2026). Everything here comes from studies on the single building blocks.

How are the two building blocks meant to work together?

NNMT uses up nicotinamide (a precursor of NAD+) and the methyl donor SAM. When NNMT was inhibited, NAD+ and SAM rose in fat cells. The NAD+ building block additionally supplies precursors from outside. That both add up in humans is an assumption, not a proven effect.

What is shown in humans?

Only for an NAD+ precursor: in the NICE trial with 90 people with peripheral artery disease nicotinamide riboside improved the 6-minute walk over 6 months (plus 7.0 versus minus 10.6 metres on placebo). The entry does not name which precursor is in the blend. There are no human data on 5-Amino-1MQ.

What did the mouse studies on 5-Amino-1MQ show?

Obese mice lost 5.1 percent of their weight in 11 days, abdominal fat was about 35 percent lighter and cholesterol about 30 percent lower with the same food intake. In old mice grip strength rose by about 40 percent, with exercise by about 60 percent.

Does 5-Amino-1MQ work as a tablet?

That has not been tested. In the animal studies 5-Amino-1MQ was injected under the skin. Cell models of the gut wall showed that the compound passes membranes well, so the authors expect good absorption. A study with tablets in animals or humans is missing.

Which side effects are known?

There are no human data on the blend or on 5-Amino-1MQ. In the mouse study the authors saw no observable side effects. NNMT also occurs in the liver and other tissues, the consequences of long-term inhibition in humans are unknown.

Seotud

Seotud tooted